Outcomes of influenza A(H1N1)pdm09 virus infection: Results from two international cohort studies

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Lynfield, Ruth ^a   Davey, Richard ^b   Dwyer, Dominic E ^c   Losso, Marcelo H ^d   Wentworth, Deborah ^e   Cozzi Lepri, Alessandro ^f   Herman Lamin, Kathy ^e   Cholewinska, Grazyna ^g   David, Daniel ^h   Kuetter, Stefan ⁱ   Ternesgen, Zelalem ^j   Uyeki, Timothy M ^k   Lane, H Clifford ^b   Lundgren, Jens ^l   Neaton, James D ^e  

^a MINNESOTA DEPARTMENT OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d HOSPITAL RAMOS MEJÍA   (Argentina)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g SP ZOZ Wojewodzki Szpital Zakazny Centrum Diagnostyki i Terapii AIDS Warszawa   (Poland)

^h Hospital Rawson   (Argentina)

ⁱ Marlow Medical Group   (United Kingdom)

^j MAYO CLINIC   (United States)

^k CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^l Mental Health Services CPH   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; GENERAL WARD; HIGH RISK POPULATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE DEFICIENCY; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; OUTPATIENT; PATIENT TRANSPORT; PREGNANT WOMAN; PREVALENCE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEASONAL VARIATION; SMOKING; SURVIVAL RATE; WARD; CLASSIFICATION; GENETICS; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; MIDDLE AGED; RISK FACTOR; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MORTALITY; PATIENT OUTCOME ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84903885738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101785     Document Type: Article

References (45)

1. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
2. World Health Organization. Influenza: surveillance and monitoring. Available: http://www.who.int/influenza/surveillance-monitoring/en/. Accessed 2013 Oct 16.
3. Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, et al. (2011) Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 52 suppl 1: S75-82.
4. Centers for Disease Control and Prevention. Seasonal Influenza (Flu). Available: http://www.cdc.gov/flu/weekly/. Accessed 2013 Oct 16.
5. Fleming DM, van der Velden J, Paget WJ (2003) The evolution of influenza surveillance in Europe and prospects for the next 10 years. Vaccine; 21: 1749-1753.
6. Van Kerkhove MD, Vandemaele KAH, Shinde V, Jaramillo-Guitierrez GJ, Koukounari A, et al. (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Medicine 8: e1001053.
7. Dwyer DE; INSIGHT Influenza Study Group (2011) Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies. Vaccine 29 Suppl 2: B56-62.
8. Szewczuk E, Thapa K, Anninos T, McPhie K, Higgins G, et al. (2010) Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness. BMC Infectious Disease 10: 113.
9. Food and Drug Administration. (2011) Clinical/antimicrobial. Influenza: Developing drugs for treatment and/or prophylaxis. Final guidance for industry. April 2011. Available: http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm064980.htm. Accessed 2013 Nov 23.
10. Ison M, deJong MD, Gilligan KJ, Higgs ES, Pavia AT, et al. (2010) End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease. J Infect Dis 201: 1654-1662.
11. van Hoek AJ, Underwood A, Jit M, Miller E, Edmunds WJ (2011) The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study. PLoS One 6(3): e17030.
12. Cox CM, D'Mello T, Perez A, Reingold A, Gershman K, et al. (2012) Increase in rates of hospitalization due to laboratory-confirmed influenza among children and adults during the 2009-2010 influenza pandemic. J Infect Dis 206:1350-1358.
13. Cheng VCC, To KKW, Tse H, Hung IF, Yuen KY (2012) Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Micro Rev 25:223-263.
14. Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB (2012) Critical illness from 2009 Pandemic influenza A(H1N10virus and bacterial co-infection in the United States. Crit Care Med 40: 1487-1498.
15. Brun-Buisson C, Richard JCM, Mercat A, Thievaut ACM, Brochard L, et al. (2011) Early corticosteroids in severe influenza A/H1N1pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 183: 1200-1206.
16. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, et al. (2009) Critically ill patients with 2009 influenza A(H1N1) infection in Canada. J Am Med Assoc 302: 1872-1879.
17. ANZIC Influenza Investigators (2009) Critical care services and 2009 H1N1 influenza infection in Australia and New Zealand. New Engl J Med 361: 1925-1934.
18. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, et al. (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 36: 1935-1944.
19. Skarbinski J, Jain S, Bramley A, Lee EJ, Huang J, et al. (2011) Hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in the United States- September- October 2009. Clinical Infect Dis (Suppl 1): S50-S59.
20. Louie JK, Acosta M, Winter K, Jean C, Gavali S, et al. (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. J Am Med Assoc 302: 1896-1902.
21. Campbell A, Rodin R, Kripp R, Mao Y, Hong Z, et al. (2010) Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. Can Med Assoc J 182: 349-355.
22. Belongia EA, Irving SA, Waring SC, Coleman LA, Meece JK, et al. (2010) Clinical characteristics and 30-day outcomes for influenza A 2009(H1N1), 2008-2009(H1N1), and 2007-2008 (H3N2) infections. J Am Med Assoc 304: 1091-1098.
23. Venkata C, Sampathkumar P, Afessa B (2010) Hospitalized patients with 2009 H1N1 influenza infection: the Mayo Clinic experience. Mayo Clin Proc 85: 798-805.
24. Helferty M, Vachon J, Tarsuk J, Rodin R, Spika J, et al. (2010) Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ 182: 1981-1987.
25. Martin-Loeches I, Diaz E, Vidaur L, Torres A, Laborda C, et al. (2011) Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients. Crit Care 15: R286.
26. Davey RT Jr, Lynfield R, Dwyer DE, Losso M, Cozzi-Lepri A, et al. (2013) The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. PLoS One 8: e57121.
27. Khandaker G, DIerig A, Rashid H, King C, Heron L, et al. (2011) Systemic review of clinical and epidemiological features of the pandemic influenza A(H1N1)2009. Influenza Other Respir Viruses 5: 148-156.
28. Myles PR, Semple MG, Lim WS, Openshaw PJM, Gadd EM, et al. (2012) Predictors of clinical outcome in a national hospitalized cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax 67: 709-717.
29. Karlsson EA, Marcelin G, Webby R, Schultz-Cherry S (2012) Review on the impact of pregnancy and obesity on influenza virus infection. Influenza Other Respir Viruses 6: 449-460.
30. Mosby LG, Rasmussen SA, Jamieson DJ (2011) 2009 pandemic influenza A (H1N1) in pregnancy: a systemic review of the literature. Am J Ob Gyn 205: 10-18.
31. Almond MH, Edwards MR, Barclay WS, Johnston SL (2013) Obesity and susceptibility to severe outcomes following respiratory viral infections. Thorax 68: 684-686.
32. Cordero E, Aydillo T, Farinas MC, Pano-Pardo JR, Pachon J (2012) Immunosuppressed patients with pandemic A 2009(H1N1) virus infection. Eur J Clin Microbiol Infect Dis 31: 547-556.
33. Sheth AN, Patel P, Peters PJ (2011) Influenza and HIV: Lessons from the 2009 H1N1 influenza pandemic. Curr HIV/AIDS Rep 8: 181-191.
34. Fowlkes AL, Arguin P, Biggerstaff MS, Gindler J, Blau D, et al. (2011) Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009. Clin Infect Dis 52 Suppl 1: S60-68.
35. Yang P, Deng Y, Pang X, Shi W, Li X, et al. (2010) Severe, critical and fatal cases of 2009H1N1 influenza in China. J Infect 61: 277-283.
36. Hanshaoworaku W, Simmerman JM, Narueponjirakul U, Sanasuttipun W, Shinde V, et al. (2009) Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 4(6): e6051
37. Viasus D, Pano-Pardo JR, Pachon J, Campins A, Lopez-Medrano F, et al. (2011) Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 5: 738-746.
38. Hewagama S, Walker SP, Stuart RL, Gordon C, Johnson PDR, et al. (2010) 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin Infect Dis 50: 686-690.
39. South East Asia Infectious Disease Clinical Research Network (2013) Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomized controlled trial. BMJ 346: F3039.
40. Joseph C, Togawa Y, Shindo N (2013) Bacteria and other viral infections associated with influenza. Influenza Other Respir Viruses 7 Suppl 2: 105-113.
41. Beadling C, Slifka MK (2004) How do viral infections predispose patients to bacterial infections? Curr Opin Infect Dis 17: 185-191.
42. Palacios G, Hornig M, Cisterna D, Savji N, Bussetti AV, et al. (2009) Streptococcus pneumonia coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 4(12): e8540.
43. Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam J (2013) Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 Influenza A(H1N1) pandemic: a systematic review and meta- analysis in hospitalized patients. J Infect Dis 207: 553-563.
44. Ortiz, JR, Rudd KE, Clark DV, Jacob ST, West TE (2013) Clinical research during a public health emergency: a systemic review of severe pandemic influenza management. Crit Care Med 41: 1345-1352.
45. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, et al. (2013) Populations at risk for severe or complicated influenza illness: systemic review and meta-analysis. BMJ 347: f5061